Ticagrelor for the treatment of acute coronary syndromes

NICE technology appraisals [TA236] Published date:

NICE recommends ticagrelor combined with low-dose aspirin for up to a year as a possible treatment for some people with acute coronary syndromes (see below).

Who can have ticagrelor?

You should be able to have ticagrelor if you:

  • have a condition called ST-segment elevation myocardial infarction (major heart attack) that your cardiologist intends to treat with a procedure to widen your narrowed artery (called primary percutaneous coronary intervention)
  • a condition called non-ST-segment elevation myocardial infarction (mild heart attack) or
  • have been admitted to hospital with unstable angina.

If you are treated with ticagrelor because you have unstable angina, this diagnosis should be confirmed, ideally by a cardiologist, before you are offered more treatment with ticagrelor.

Why has NICE said this?

NICE looks at how well treatments work, and also at how well they work in relation to how much they cost the NHS.

NICE recommended ticagrelor because it works better than other treatments available on the NHS. Although it also costs more than other treatments, this was justified by the benefits it provided.

Get involved